Pulmonx Corporation
LUNG
$1.62
-$0.01-0.61%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.88% | 5.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.88% | 5.86% | |||
| Cost of Revenue | -18.11% | 7.41% | |||
| Gross Profit | -6.70% | 5.27% | |||
| SG&A Expenses | -4.13% | 2.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.16% | 4.21% | |||
| Operating Income | 2.78% | -1.65% | |||
| Income Before Tax | 7.78% | -4.77% | |||
| Income Tax Expenses | -27.68% | 31.11% | |||
| Earnings from Continuing Operations | 8.01% | -5.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.01% | -5.02% | |||
| EBIT | 2.78% | -1.65% | |||
| EBITDA | 2.47% | -1.54% | |||
| EPS Basic | 9.17% | -3.79% | |||
| Normalized Basic EPS | 8.93% | -3.53% | |||
| EPS Diluted | 9.17% | -3.79% | |||
| Normalized Diluted EPS | 8.93% | -3.53% | |||
| Average Basic Shares Outstanding | 1.25% | 1.19% | |||
| Average Diluted Shares Outstanding | 1.25% | 1.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||